Maravai Lifesciences Holdings, Inc. SEC filings MRVI
Maravai Lifesciences Holdings, Inc. has 425 filings in SEC EDGAR's recent list, going back to Sep 8, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K | Current report | Nov 4, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Oct 9, 2026 | Oct 8, 2026 |
| 4 | Insider transaction | Oct 1, 2026 | Sep 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 29, 2026 | — |
| 4 | Insider transaction | Sep 9, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 4 | Insider transaction | Aug 11, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 8, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 29, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 23, 2026 | — |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 144 | Notice of proposed sale | Jun 10, 2026 | — |
| 144 | Notice of proposed sale | Jun 9, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
|
Jun 3, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2026 | May 26, 2026 |
| 4/A | Form 4/a | May 28, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 26, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2026 | — |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 24, 2026 | May 26, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 16, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2026 | Feb 25, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Jan 20, 2026 | Jan 15, 2026 |
| 4 | Insider transaction | Jan 20, 2026 | Jan 15, 2026 |
| 144 | Notice of proposed sale | Dec 23, 2025 | — |
| 144 | Notice of proposed sale | Dec 19, 2025 | — |
| 4 | Insider transaction | Dec 9, 2025 | Dec 5, 2025 |
| 4 | Insider transaction | Nov 18, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 13, 2025 | Nov 11, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 31, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2025 | Oct 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 17, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change
|
Aug 11, 2025 | Aug 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2025 | — |
| 8-K |
Current report
Auditor change
|
Jul 18, 2025 | Jul 16, 2025 |
| 4 | Insider transaction | Jul 16, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jul 10, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 30, 2025 |
| 3 | Initial insider ownership | Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 25, 2025 | Jun 22, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 8, 2025 |
| 3 | Initial insider ownership | Jun 10, 2025 | Jun 8, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 9, 2025 | Jun 8, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 29, 2025 | — |
| 4 | Insider transaction | May 28, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 15, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2025 | May 22, 2025 |
| S-8 | Employee stock plan registration | May 12, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| ARS | Annual report to shareholders | Apr 18, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 18, 2025 | May 22, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Restatement
|
Mar 18, 2025 | Mar 17, 2025 |
| NT 10-K | Filing | Mar 4, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 25, 2025 | Feb 25, 2025 |
| UPLOAD | Letter from the SEC | Feb 20, 2025 | — |
| CORRESP | Letter to the SEC | Feb 19, 2025 | — |
| 4 | Insider transaction | Feb 19, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 31, 2025 |
| 144 | Notice of proposed sale | Jan 31, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 28, 2025 | — |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 17, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jan 8, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Other events
|
Dec 18, 2024 | Dec 18, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 16, 2024 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 9, 2024 |
| 3 | Initial insider ownership | Dec 5, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 5, 2024 | Dec 3, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Nov 14, 2024 | Nov 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Nov 12, 2024 | Oct 31, 2024 |
| 4 | Insider transaction | Nov 12, 2024 | Oct 31, 2024 |
| 4 | Insider transaction | Nov 12, 2024 | Oct 31, 2024 |
| 4 | Insider transaction | Nov 12, 2024 | Nov 11, 2024 |
| 4 | Insider transaction | Nov 12, 2024 | Oct 31, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 29, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 4 | Insider transaction | Oct 16, 2024 | Oct 15, 2024 |
| UPLOAD | Letter from the SEC | Sep 17, 2024 | — |
| 8-K |
Current report
Material agreement
|
Sep 12, 2024 | Sep 10, 2024 |
| CORRESP | Letter to the SEC | Aug 16, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 29, 2024 | Jul 23, 2024 |
| UPLOAD | Letter from the SEC | Jul 19, 2024 | — |
| 4 | Insider transaction | Jul 16, 2024 | Jul 15, 2024 |
| CORRESP | Letter to the SEC | Jun 24, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2024 | Jun 10, 2024 |
| SC 13G | Ownership over 5% (passive) | Jun 10, 2024 | — |
| 4 | Insider transaction | May 30, 2024 | May 28, 2024 |
| 144 | Notice of proposed sale | May 28, 2024 | — |
| 144 | Notice of proposed sale | May 28, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| SC 13G | Ownership over 5% (passive) | May 14, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 4 | Insider transaction | May 2, 2024 | Apr 30, 2024 |
| 4 | Insider transaction | May 2, 2024 | Apr 30, 2024 |
| 4 | Insider transaction | May 2, 2024 | Apr 30, 2024 |
| 4 | Insider transaction | May 2, 2024 | Apr 30, 2024 |
| 4 | Insider transaction | May 2, 2024 | Apr 30, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 25, 2024 | May 23, 2024 |
| 4 | Insider transaction | Apr 16, 2024 | Apr 15, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 15, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 28, 2024 | — |
| 8-K |
Current report
Results of operations
|
Feb 22, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 15, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 15, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 15, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 15, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MRVI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1823239
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.